IDT Biologika
Dessau-Rosslau, Germany idt-biologika.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
IDT Biologika is a CDMO that develops and manufactures biologics and sterile injectables for pharmaceutical and biotech companies. It works on vaccines, cell and gene therapies, proteins, monoclonal antibodies, biosimilars, and sterile injectables from development through commercial manufacturing. Its sites are in Dessau-Rosslau and Magdeburg, Germany.
IDT Biologika is a CRDMO in Dessau-Rosslau, Germany, founded in 1993. It lists 10 services, including Process development, Analytical development and Drug substance manufacturing. It names GMP on its listing.
Services
Process development
Develops and optimizes processes for vaccines, viral vectors, and other biologics, including support for GMP, quality assurance, analytical methods, and regulatory requirements.
Analytical development
Provides analytical method development, transfer, implementation, validation, release testing, and stability studies.
Drug substance manufacturing
Manufactures clinical and commercial drug substance for cell-culture and microbial-based products using scalable upstream and downstream technologies.
Aseptic fill-finish
Provides sterile liquid and lyophilized fill-finish for vaccines, recombinant proteins, antibodies, viral vectors, and other sterile injectables in vials and prefilled syringes.
Lyophilization
Offers lyophilized fill-finish for sterile injectables and vaccine products.
Secondary packaging
Provides secondary packaging for filled products.
Quality control and analytics
Supports product testing and analytical services for sterile injectables and biologics.
Regulatory support
Supports CMC documents and regulatory filings for clients.
2 more services
- Cell lines
- Biomanufacturing services
How to order from IDT Biologika
They take quote requests by email. You can contact them directly from this page, or request a quote through Midgard.
Capabilities
- Assays and studies
- Process development
- Lyophilization
- Fill-finish
- Analytical development
- Stability studies
- Antibodies
6 more
- mRNA
- Method development
- Method transfer
- Method implementation
- Validation (ICH)
- Release testing
- Scale and capacity
- 200L
- 800L
- 2,000L+
- Batch sizes up to 500,000 vials
- Up to 100 million vials per year
- Therapeutic areas
- Infectious diseases
- Cancer
- Metabolic diseases
- Neurological diseases
- Genetic diseases
Instruments and platforms
- High-speed filling line
- Isolator filling lines
- BSL-2 facilities
Modalities and species
- Modalities
- Small molecule
- Antibody
- mRNA
- Viral vector
- Cell therapy
- Recombinant protein
- Vaccine
- Biosimilar
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CRDMO
- Founded
- 1993
Locations
- Based in
- Dessau-Rosslau, Germany
- Sites
- Magdeburg, Germany
- Serves
- Global, American customers, Europe
Contacts
- General enquiry
- info@idt-biologika.com on their site
Public records
- Wikidata
- Q1653406 source